Viewing Study NCT00477802


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-03-04 @ 3:12 PM
Study NCT ID: NCT00477802
Status: TERMINATED
Last Update Posted: 2009-02-16
First Post: 2007-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease
Sponsor: University of Cincinnati
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 06122801
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Alberto Espay, MD
Old Organization: University of Cincinnati

Collaborators

Collaborators

Name Class View
None INDUSTRY View